Details for 2019188210
Up to date per 03.04.2026
Actions
Details for 2019188210
Deleted
European Patent
19.02.2020 A
25.01.2023 B1
08.07.2013
US
201361843549 P
10.06.2014
US
201462010098 P
C07C 229/08 20060101AFI20191029BHEP
Owner
Auspex Pharmaceuticals, Inc.400 Interpace Parkway Parsippany NJ 07054US
The U.S.A. as represented by the Secretary, Department of Health and Human ServicesOffice of Technology Transfer National Institutes of Health 6011 Executive Boulevard, Suite 325 MSC 7660 Bethesda, MD 20892-7660US
Representative
No representatives present
Inventor
GOLDSTEIN, David, S.6011 Executive Bolevard Suite 325 MSC 7660 Bethesda, MD 20892US
HOLMES, Courtney6011 Executive Boulevard Suite 325 MSC 7660 Bethesda, MD 20892US
ALKEN, Rudolf-GiesbertAuspex Pharmaceuticals, Inc. 400 Interpace Parkway Parsippany, New Jersey 07054US
SCHNEIDER, FrankAuspex Pharmaceuticals, Inc. 400 Interpace Parkway Parsippany, New Jersey 07054US
ZHANG, ChengzhiAuspex Pharmaceuticals, Inc. 400 Interpace Parkway Parsippany, New Jersey 07054US